Teva Branded Pharmaceutical Products R&d, Inc.

This study tested an experimental drug called TEV-48574 in 290 adults with moderate to severe ulcerative colitis or Crohn's disease. The goal was to see if the drug could help patients achieve remission or reduce bowel inflammation after 14 weeks of treatment. Participants receiv…

This study tested whether a monthly injection of fremanezumab can prevent chronic migraines in children aged 6 to 17. About 292 participants received either the drug or a placebo, and researchers tracked how many headache days they had over 12 weeks. The goal was to see if the dr…

This study tested whether a digital inhaler system (a smart inhaler with an app) helps people with asthma gain better control of their condition. About 333 people aged 13 and older with asthma took part. Half used the smart inhaler system, and the other half used their usual resc…

This study tested a drug called fremanezumab, given as a shot under the skin once a month or once every three months, to prevent migraines in 365 Chinese adults. The main goal was to see if it reduced the number of migraine days per month compared to a placebo. The drug is design…